Concourse Financial Group Securities’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 3497 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4851 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4837 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4876 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4877 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4817 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 4742 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 4679 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 4549 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 4521 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4327 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 4360 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 4292 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 4359 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4262 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4143 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4046 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3955 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3796 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3687 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3690 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3650 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 3396 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 3677 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 3641 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 3519 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3151 |
|